Effects of metyrapone on liver microsomal drug oxidations.
D000083:Acetanilides / Q000037:antagonists & inhibitors; D000632:Aminopyrine / Q000037:antagonists & inhibitors; D000818:Animals; D003864:Depression, Chemical; D006591:Hexobarbital / Q000037:antagonists & inhibitors / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D008797:Metyrapone / Q000494:pharmacology*; D008862:Microsomes, Liver / Q000187:drug effects* / Q000201:enzymology*; D009020:Morphine / Q000378:metabolism; D009249:NADP / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology; D051381:Rats; D012890:Sleep / Q000187:drug effects; D013268:Stimulation, Chemical; D014241:Trichloroethylene / Q000378:metabolism; D014439:Tyramine / Q000378:metabolism
D000083:Acetanilides; D000632:Aminopyrine; D014241:Trichloroethylene; D009249:NADP; D009020:Morphine; D006591:Hexobarbital; D014439:Tyramine; D010634:Phenobarbital; D008797:Metyrapone